Sheridan Legacy Group invests in Smile Doctors

Sheridan Legacy Group said Monday it invested in Smile Doctors. Financial terms weren’t announced. The Thurston Group also invested. Austin-based Smile Doctors provides management services to orthodontic practices focused on both adults and children in Texas and Georgia. Twin Brook Capital Partners provided financing.


CHICAGO–(BUSINESS WIRE)–Sheridan Legacy Group, a Chicago-based lower middle-market private equity firm, announced today its investment in Smile Doctors (the “Company”) a Dental Services Organization (“DSO”).

Smile Doctors, headquartered in Austin, TX, provides management services to orthodontic practices focused on both adults and children in Texas and Georgia. The Company’s unique, high-energy approach to the patient experience and its dedication to clinical excellence has helped Smile Doctors become best-in-class within its markets. The Company prides itself on its patient experience and its ability to make its superior orthodontics services affordable to nearly all patients.
“Smile Doctors has experienced exceptional growth within an attractive market. The Company’s positioning within its markets, its dedication to an upbeat, high quality patient experience, and its clinical expertise make Smile Doctors a unique platform,” said Jonathan Lewis, Partner of Sheridan Legacy Group. “We are excited to partner with Scotte Hudsmith, Dr. Scott Law, Dr. Dana Fender and the entire management team to support the Company’s ongoing success and accelerate its growth.”
Scotte Hudsmith, the CEO of Smile Doctors, said, “Sheridan is an ideal strategic partner for us. The team’s deep understanding of the consumer-facing healthcare market, operational expertise and strategic counsel will enable us to leverage and expand our existing operations while maintaining our focus on patient experience and preserving our strong corporate culture.” Dr. Dana Fender, Head of Clinical M&A, added, “We believe that Sheridan’s insights will help us execute the roll-out of the Smile Doctors model across a broader geography and allow us to positively impact the lives of more patients with our unique, fun approach to the patient experience.” Dr. Scott Law, Chief Clinical Officer, said, “In Sheridan, we found a partner who shares our commitment to clinical excellence as well as our vision for growing the Company. We are looking forward to the positive impact our combined work will have on patients and orthodontic care as a whole.”
The transaction was led by Lewis, Sean Dempsey and Chase Culbertson. Additional capital was provided by Thurston Group, and the Chicago Corporation advised Smile Doctors on the transaction. The transaction was financed by Twin Brook Capital Partners. Terms were not disclosed.